Using the N-terminus of cyclin A1 in a two-hybrid screen as a bait, we identified a Xenopus protein, XDRP1, that contains a ubiquitin-like domain in its N-terminus and shows significant homology in its C-terminal 50 residues to Saccharomyces cerevisiae Dsk2 and Schizosaccharomyces pombe dph1. XDRP1 is a nuclear phosphoprotein in Xenopus cells, and its phosphorylation is mediated by cyclin A-dependent kinase. XDRP1 binds to both embryonic and somatic forms of cyclin A (A1 and A2) in 
Introduction
Proteolysis plays an essential role in the periodic events of cell-cycle progression through the irreversibility caused by the degradation of cyclin and other proteins, such as Pds1/Cut2 (see review by King et al., 1996a) . Mitotic cyclins are rapidly degraded at the exit of mitosis and their degradation is necessary to enter the next cell cycle. The degradation of mitotic cyclins is mediated by the ubiquitin-proteasome machinery (Sudakin et al., 1995; Hochstrasser, 1996; King et al., 1996b) , and this process requires an intact destruction box; a conserved nineresidue motif in their N-terminus (Glotzer et al., 1991) . Several other proteins involved in the regulation of mitotic events, such as chromosome segregation and spindle formation, possess a similar motif, and their degradation is also controlled by the ubiquitin-proteolytic machinery, activation of which is determined differently at least in part by members of the fizzy family of proteins including Cdc20/slp1 and Cdh1/Hct1 (Cohen-Fix et al., 1996; Funabiki et al., 1996; Juang et al., 1997; Sigrist and Lehner, 1997) . These proteins activate the selective ubiquitin ligase E3, known as the anaphase-promoting complex (APC) or cyclosome (King et al., 1995; Sudakin et al., 1995; Schwab et al., 1997; Visintin et al., 1997) . The initiation of cyclin B degradation is also triggered by a direct cleavage of the N-terminal domain of cyclin by the 26S proteasome (Tokumoto et al., 1997) .
During the rapid cleavage cell cycles of early embryos, mitotic cyclins are destroyed only during a narrow time window Sudakin et al., 1995) . Moreover, cyclins A and B are destroyed at slightly different times during mitosis (Lehner and O'Farrell, 1989; Minshull et al., 1990; Pines and Hunter, 1990; Hunt et al., 1992) , with cyclin A being degraded prior to cyclin B, and the cyclin A-associated kinase activity increases and decreases earlier in the cell cycle than the cyclin B-associated kinase activity (Minshull et al., 1990) , suggesting that functional differences exist between cyclin A and cyclin B at distinct times of mitosis (Luca et al., 1991) .
Mitotic cyclins are characterized by two conserved motifs in the amino acid sequence; the destruction box and the cyclin box. The degradation of mitotic cyclins requires the destruction box of the N-terminus for its recognition by the ubiquitin-mediated proteolytic machinery (Glotzer et al., 1991; Kobayashi et al., 1992; Lorca et al., 1992) . Apart from the destruction box, the N-termini of mitotic cyclins contain other conserved motifs upstream of the start of the conserved cyclin box, which is required for association with Cdks. For example, the N-terminus of cyclin B1 contains a nuclear export signal LCQAFS, and both cyclins A and B contain autophosphorylation sites (Pines and Hunter, 1994; Klotzbucher et al., 1996; Hagting et al., 1998; Toyoshima et al., 1998) . Cyclin A contains a conserved motif, FxxVDE, between the destruction box and the start of cyclin box, which has recently been shown to be a cleavage site of ICE-like caspase for apoptotic proteolysis of cyclin Stack and Newport, 1997) . These imply that the conserved motifs in the N-terminus of mitotic cyclins between the stretch of the destruction box and the cyclin box could specify the distinct unknown functions of mitotic cyclins A and B during mitosis. To investigate the role(s) of these motifs with the aim of understanding the selective timing of degradation of cyclins A and B, we performed a yeast two-hybrid screen to isolate the cyclin A-specific interacting factors using the N-terminal domain of cyclin A as a bait. The major interacting species, XDRP1, was a Xenopus Dsk2-related protein in yeast that appears to be involved in the spindle checkpoint pathway. XDRP1 interacts with A-type cyclins, but not with cyclin B. Surprisingly, high levels of XDRP1 inhibited the degradation of cyclin A, but not that of cyclin B, and blocked cleavage cell division of embryos. Deduced amino acid sequence of Xenopus XDRP1. The deduced amino acid sequence of ORF of XDRP1 was shown, and its numbers are indicated at the right of the sequence. The N-terminal ubiquitin-like sequences (7-78) are shaded and seven identical residues with ubiquitin and four XDRP1-related proteins are shown by letters in a black rectangle. Similarly, the C-terminal yeast Dsk2p-like sequence (539-585) and identical residues are shown. Seven conserved repeats in the middle (171-240) and three conserved repeats (around 350-450) are underlined. The M-NPX sequences scattered are also shaded. The structures of frog XDRP1, budding yeast Dsk2, fission yeast dph1 and Nematoda F15C11.2 are schematically shown on the right of the sequence.
Results

Xenopus XDRP1 is a novel N-terminal ubiquitin-like protein
To search for factors that interacted with conserved domains in the N-terminus of cyclin A, we used the N-terminal 160 residues of Xenopus cyclin A1 fused to the Gal4 DNA-binding domain as a bait in a two-hybrid screen. Twenty out of 41 strongly interacting clones were found to be identical in sequence, containing a 2.3 kb insert of a full-length cDNA clone (Figure 1 ). The putative ORF of this clone, Xenopus Dsk2-related protein 1 (XDRP1), was composed of 585 residues with a calculated molecular mass of 62 kDa. A search of the databases revealed that the N-terminus of XDRP1 had strong homology to residues 39-70 of ubiquitin (53% identity), and that the C-terminus showed a high similarity to the C-terminus of budding yeast Dsk2 (Biggins et al., 1996) and fission yeast dph1 (He et al., 1998 ) (42 and 51% identity, respectively, in the 47 C-terminal residues), although the yeast proteins are smaller (39 and 36 kDa) (Figure 1 ). Nematode, mouse and human homologues were identified in the databases, although no full-length clones have yet been reported. The middle of the protein contains a number of short conserved repeated sequences, in which the sequence MXNPD/E/Q appeared, that were also observed in the yeast proteins (see Figure 1) , and the sequences around residues 360 and 530 were unique to this protein. An alternative spliced form of XDRP1 consisting of 600 amino acid residues are isolated (data not shown), where 15 amino acid residues, EEIVIGET-ACVLEFK, are inserted into the ubiquitin-like domain, between amino acids 33 and 34 (Figure 1 , indicated by a dot in the sequence).
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XDRP1 persists in Xenopus cells as a nuclear phosphoprotein
We raised polyclonal antibodies against bacterially expressed XDRP1. Figure 2A shows that the antiserum against XDRP1 easily detected a single polypeptide with an apparent molecular weight of~68 kDa by immunoblotting Xenopus egg extracts. The concentration of XDRP1 in eggs was estimated as 0.5-1 ng/egg,~8-16 nM (data not shown), using immunoblotting with bacterially expressed GST-XDRP1 protein as a standard. XDRP1 protein was detected as a faster-migrating band through the early stages of oogenesis ( Figure 2A ). Two bands were detected in Xenopus embryos and cultured cells (lanes 3-5). The slower-migrating band detected in eggs ( Figure 2B , lane 1) was converted to the faster-migrating one by treatment with lambda phosphatase (lane 3) and phosphatase inhibitors blocked this band shift (lane 4), from which we conclude that the upper XDRP1 band was a phosphorylated form of the lower one. A non-or hypo-phosphorylated form of XDRP1 was present in immature oocytes ( Figure 2A , lane 1) and phosphorylated forms appeared during oocyte maturation (lane 2). At later stages of development and in cultured cells, both forms were detected (lanes 3-5). Dephosphorylated form appeared at 40-50 min after activating egg to drive the cell cycle ( Figure 2C ), although no typical cell-cycle pattern of phosphorylation was observed at its protein level. When 35 S-labelled XDRP1 in egg extracts was immunoprecipitated with anti-XDRP1 antibody, however, phosphorylated form was detected mainly at CSF-arrested extracts and non-phosphorylated form was detected in interphase ( Figure 2D ). Therefore, XDRP1 is phosphorylated at M phase, but not in interphase. To investigate the subcellular localization of XDRP1, cultured Xenopus cells were stained using anti-XDRP1 antiserum. XDRP1 protein was predominantly localized to the nucleus in interphase cells ( Figure 3A) , while in mitotic cells, no particular subcellular location was observed. XDRP1 was detected in both nuclear and cytoplasmic fractions of cell lysates ( Figure 3B ). The nuclear form had a lower mobility than the cytoplasmic one (lane 1), thus suggesting that the phosphorylated form of XDRP1 is located in the nucleus.
XDRP1 binds to full-length cyclin A1 and A2, but not to B-type cyclins
We tested binding of XDRP1 with cyclin A by growth and β-galactosidase in the yeast two-hybrid system, since (B) Subcellular fractionation. WAK cells were fractionated into the cytoplasmic and the nuclear fractions as described in the Materials and methods. Three micrograms of total proteins in each fraction were applied on the gel and were co-immunoblotted with both anti-XDRP1 antibody and anti-RCC1 antibody. Nuclear protein RCC1 was used as a control to check the fractionation. Lane 1, nuclear fraction; lane 2, cytosol; lane 3, total cell fraction. XDRP1 was originally isolated by yeast two-hybrid screen using the N-terminal domain of cyclin A1 as bait (positions 1-160). Both assays showed XDRP1 to bind to the N-terminal domain of cyclin A1 ( Figure 4A ).
Next we tested the binding of cyclin A1 to XDRP1 in Xenopus egg extracts. The full-length cyclin A1 mRNA was translated in the presence of [ 35 S]methionine in frog egg extracts, as described in Materials and methods. Recombinant GST-XDRP1 was then added, followed by affinity chromatography on GSH-Sepharose to isolate the proteins that bound to the bacterially expressed GST-XDRP1. Figure 4B shows cyclin A1 was retained when GST-XDRP1 was added ( Figure 4B , lane 6), and not with GST alone (lane 2). The binding of cyclin A to GST-XDRP1 was significantly lower than the binding of cyclin A to GST-CDK2, which acted as a positive control in this experiment ( Figure 4B , lane 4). GST-XDRP1 also bound to Xenopus and human cyclin A2, the form of cyclin A found in somatic cells ( Figure 4C , lanes 5 and 6). We also checked the binding of XDRP1 to cyclin A1 in yeast cells, where a full-length Xenopus cyclin A1 overproduced from a yeast-inducible vector could be isolated by addition of GST-XDRP1 to the lysate followed by affinity chromatography on GSH-Sepharose and immunoblotting with anti-cyclin A1 antibody (data not shown).
Next we tested interactions between XDRP1 and cyclin A in Xenopus cells. Constructs of T7-His-tagged XDRP1 and HA-tagged cyclin A2 were transfected into WAK cells and both proteins were expressed in vivo ( Figure  4D , lane 4). Then, T7-His-XDRP1 proteins were precipitated with TALON metal affinity resin, and XDRP1-bound materials were immunoblotted with anti-HA antibody against HA-cyclin A2. Figure 4D shows that XDRP1 interacted with cyclin A2 in cells (lane 8). When immunoprecipitation using anti-XDRP1 antibody was carried out after translating cyclin A1 mRNA in the Xenopus egg extracts, labelled cyclin A1 was weakly co-precipitated with anti-XDRP1 antibody (see arrowhead in Figure 2D ).
It proved difficult to demonstrate interactions between them in Xenopus cell extracts using immunoprecipitation with either anti-XDRP1 or anti-cyclin A1 antibodies, followed by immunoblotting. It was clear that the interaction between XDRP1 and cyclin A was weaker than that between CDK2 and cyclin A (see Figure 4B) .
Next, to test whether XDRP1 bound to B-type cyclins,
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cyclins A and B were labelled with [ 35 S]methionine in the egg extracts and tested for their ability to bind to GST-XDRP1. XDRP1 bound to Xenopus cyclin A1 ( Figure 4E , lane 5) in the frog egg extract, but not to cyclin B1 (lane 6) or cyclin B2 (lane 7). Even when both cyclins A and B were co-translated, neither cyclin B1 nor cyclin B2 bound to GST-XDRP1 ( Figure 4E , lanes 8 and 9). Therefore, XDRP1 appears to bind to cyclin A specifically and not cyclin B. The same results were obtained by two-hybrid assay (both histidine-prototrophic growth and increased β-galactosidase activity) using the equivalent peptides of the N-terminal cyclin B (positions 1-132 in cyclin B1 and 1-127 in cyclin B2) (data not shown).
XDRP1 binds to the cyclin A-CDK complex and XDRP1 phosphorylation depends upon cyclin A-dependent kinase
To test whether XDRP1 could bind to cyclin A-CDK complexes, Cdc2 was labelled with [ 35 S]methionine in egg extracts, and affinity chromatography with GST-XDRP1 was performed as before. Both cyclin A1 and Cdc2 were retained on GSH-Sepharose in the presence of GST-XDRP1 ( Figure 5A , lane 6). A similar result was obtained for CDK2 (data not shown). To confirm that XDRP1 actually binds to the cyclin-CDK complex, we examined whether the GST-XDRP1 displayed histone H1 kinase activity. Figure 5B shows that the GSH-Sepharose beads carrying GST-XDRP1 possessed H1 kinase activity ( Figure 5B , lane 4) only when cyclin A1 mRNA was translated in the extract (lanes 3 and 4). GST alone did not retain cyclin A or significant kinase activity (lanes 1 and 2). Since XDRP1 binds to the cyclin A-CDK complex, whether XDRP1 phosphorylation is mediated by cyclin Adependent kinase or not was tested ( Figure 5C ). GST-XDRP1 was phosphorylated when cyclin A1 was translated in egg extracts ( Figure 5C , lane 2), where CDK activity was elevated by cyclin A1 expression (data not shown). Increasing amounts of butyrolactone I added to the extracts inhibited phosphorylation of GST-XDRP1 ( Figure 5D , lanes 3 and 4). GST-XDRP1 was directly phosphorylated by the immuno-purified cyclin A-cdc2 complex in vitro (data not shown). Therefore, cyclin Adependent kinase contributes to phosphorylation of XDRP1.
The ubiquitin-like domain of XDRP1 is necessary but not sufficient for interaction with cyclin A We tested which domains of XDRP1 were required for the interaction with cyclin A. N-and C-terminal deletions were made and their binding abilities for cyclin A1 were tested by two-hybrid assay ( Figure 6A ). Deletions of the ubiquitin-like domain in the N-terminus (76-585) abolished its binding with cyclin A1, but that of the C-terminal conserved Dsk2-like domain did not (1-538), showing a requirement for the N-terminal ubiquitin-like domain for XDRP1 to interact with cyclin A. The nonconserved middle region of XDRP1 was also required for 5013 its binding to cyclin A1, however, because the N-terminus alone showed no interaction.
Residues surrounding the major phosphorylation site in cyclin A are necessary for interaction with XDRP1 To define the region of cyclin A1 that was required for XDRP1 binding, we prepared a number of mutants and synthesized the corresponding 35 S-labelled proteins in egg extracts ( Figure 6B , upper panel) followed by affinity chromatography using GST-XDRP1 ( Figure 6B , lower panel). The N-terminal fragment (1-160), which was originally used as a bait for two-hybrid screening, bound to XDRP1 as expected, but its binding was rather poor in comparison with full-length cyclin A1 ( Figure 6B , lanes 2 and 3). No signal was detected with GST alone (lane 1). The construct comprising residues 133-418 of cyclin A1 bound to XDRP1 as well as the full-length protein (lanes 3 and 7), whereas residues 161-418 did not bind at all (lane 8). The construct with an internal deletion, Δ88-144, bound to XDRP1 with slightly reduced efficiency (lane 5) compared with full-length cyclin A1 (lane 3). These results suggest that the residues between 133 and 160 of cyclin A1 are required for XDRP1 binding. A destruction-box mutant ATVA bound to XDRP1 normally in egg extracts (lane 4). Therefore, the destruction box, which is necessary for the ubiquitin-mediated proteolysis of mitotic cyclins, was not required for XDRP1 binding. The sequence around 133-160 contains a motif conserved among A-type cyclins, in which phosphorylation site SP at 136/137 surrounded by other partially conserved residues around 130-145 is reasonably well conserved ( Figure 6C ).
It lies just upstream of the N-terminal helix that interacts with CDK2.
High levels of XDRP1 selectively inhibit the degradation of cyclin A and block the cell cycle in Xenopus embryo
To test if any function in relation to cyclin destruction could be detected, we investigated the effects of XDRP1 on cyclin degradation in Xenopus egg extracts. Cyclin A1 and/or B2 was first labelled with [ 35 S]methionine in a 1:1 mixture of reticulocyte lysate and frog egg extract, and this labelled substrate was then added to fresh egg extract, to which CaCl 2 was added to trigger the exit from M phase.
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The degradation of cyclin A1 was strongly inhibited by the addition of GST-XDRP1, but that of cyclin B was not ( Figure 7A, panel b) . However, cyclin A1 or cyclin B2 proteolysis was not inhibited in extracts to which GST or XB buffer alone was added (panel a). Because cyclin B was degraded normally in the presence of XDRP1, XDRP1 addition to the extracts did not affect the ubiquitindependent proteolytic machinery itself. Since the egg extracts contain endogenous XDRP1, we next analysed the effect of XDRP1 immunodepletion in the extracts. As shown in Figure 7A , panel c, cyclins A and B were both degraded normally in the XDRP1-immunodepleted extracts. In this experiment, Ͼ95% of endogenous XDRP1 was depleted, when checked by immunoblotting (data not shown).
To examine the effect of elevated levels of GST-XDRP1 on the cell cycle in Xenopus embryos, we injected 60 ng of GST-XDRP1 into fertilized eggs and observed its effects on cleavage ( Figure 7B ). The injection of GST-XDRP1 into one-cell stage embryo blocked cell division. The injection of similar amounts of GST alone had no obvious effects on the cleavage of embryos. The percentage showing blocking of the cell cycle was 93% (14/15 embryos) in GST-XDRP1 and 11% (2/18 embryos) in GST alone. Therefore, the increasing GST-XDRP1 protein appears to induce an inhibitory effect on the cell division in cleaving embryos, probably because of failure to degrade cyclin A.
Discussion
In this paper we identified a Xenopus protein XDRP1 that shows homology to a region of ubiquitin in its N-terminus and to the yeast proteins Dsk2 and dph1 in its C-terminus. XDRP1 was identified by virtue of its binding to a site found in the N-terminus of several kinds of cyclin A, and does not bind to B-type cyclins. XDRP1 is a nuclear phosphoprotein in Xenopus somatic cell cultures. Elevated levels of GST-XDRP1 inhibited degradation of cyclin A, but not that of cyclin B, and also blocked cell division in cleaving Xenopus embryos. Degradation assays were carried out in Xenopus CSF-arrested extracts as described in Materials and methods. Cyclin degradation was induced by adding 0.4 mM calcium to the extracts. In this experiment, 100 ng/μl of purified GST-XDRP1 was added to the extracts. The addition of GST alone (100 ng/μl) had no inhibitory effect on cyclin destruction. Panel a, XB buffer-added extracts; panel b, GST-XDRP1-added extracts; panel c, XDRP1-depleted extracts. (B) Microinjected GST-XDRP1 blocked embryonic cell division in Xenopus. GST-XDRP1 (60 ng/embryo) was injected into the fertilized eggs as described in Materials and methods. GST was injected as a control (60 ng/embryo). The eggs injected the lower concentration of GST-XDRP1 (30 ng/embryo) cleaved slowly, and as a result, an injected embryo induced incomplete gastrulation (data not shown).
Xenopus XDRP1 contains a ubiquitin-like domain in the N-terminus and shares the C-terminal conserved domains with yeast Dsk2
XDRP1 contained a short ubiquitin-like sequence in its N-terminal end (53% identity to the C-terminal half of ubiquitin). A family of proteins containing such a ubiquitin-like domain in its N-terminus has been reported; yeast Dsk2 (Biggins et al., 1996) and dph1 (He et al., 1998) , Rad23 (Watkins et al., 1993) and Xenopus An1a/b (Linnen et al., 1993) . A similarity was also observed in the C-termini of Xenopus XDRP1 and yeast Dsk2 (42% identity), and in nine repeats with nine or 10 amino acid residues in the middle region of both peptides (see Figure  1 , positions 170-240 and 370-440). Based on these molecular features, XDRP1 and Dsk2 probably share the same function in the cell cycle, which may be related somehow to the cell cycle. DSK2-1 was originally isolated as a suppressor of a kar1 allele defective for SPB duplication in budding yeast, and DSK2 overexpression caused mitotic defect with short spindle (Biggins et al., 1996) . Therefore, it is possible that XDRP1 may be involved in the spindle function in mitosis, perhaps through the interaction with cyclin A. The involvement of the cyclin A function in microtubule nucleation in mitotic spindle formation has been noted previously by several investigators (Buendia et al., 1992; Maldonado-Codina and Glover, 1992; Verde et al., 1992) , although the function in vivo of cyclin A is still unclear. The recently identified Schizo-5015 saccharomyces pombe dph1 ϩ , a homologue of DSK2, causes metaphase arrest with a short mitotic spindle when overexpressed (He et al., 1998) , which is reminiscent of our finding that high levels of GST-XDRP1 can inhibit cyclin A proteolysis and block cell division (Figure 7) .
A new motif in the N-terminal domain of cyclin A is required for XDRP1 via its N-terminal ubiquitin-like domain
Two conserved motifs in the N-terminal domain of cyclin A have been characterized so far; the destruction box and the FxxVDE motif . The destruction box is required for the recognition by the ubiquitinmediated APC-dependent pathway (Glotzer et al., 1991) . The conserved FxxVDE motif has recently been reported as a cleavage site for ICE-like caspase in apoptotic proteolysis (Stack and Newport, 1997) . Neither of these motifs was required for XDRP1 binding (Figure 6 ). Rather, XDRP1 interacted with residues 133-160, downstream of the FxxVDE motif. This region contains a phosphorylation site conserved in A-type cyclins, -139SPxMxS144-, and acidic residues around position 150 (see Figure 6C ). The interaction of XDRP1 with this new motif might be involved in the regulation of cyclin degradation as discussed below, while the N-terminal ubiquitin-like domain of XDRP1 is found to be required for cyclin A binding. We note that XDRP1 is a stable protein and there was no evidence that its N-terminal ubiquitin-like sequence was processed from full-length XDRP1.
XDRP1 is a candidate substrate for cyclin A-dependent kinase
Our results indicate that XDRP1 might be a candidate substrate for the cyclin A-CDK. XDRP1 is sharply phosphorylated during oocyte maturation (Figure 2A) , and the activity of XDRP1 phosphorylation is shown to be present at M phase in egg extracts ( Figure 2D ). Although we have shown previously that the level of cyclin A1 proteins is low in Xenopus eggs and cyclin A-cdc2 kinase fails to be detected in matured egg extrcts (Kobayashi et al., 1991) , the cyclin A-dependent kinase, even though its activity is low, would contribute to XDRP1 phosphorylation. Besides being phosphorylated by cyclin A-dependent kinase itself, XDRP1 would be phosphorylated by either other kinases or the kinases activated by cyclin A. However, cyclin B-dependent kinase (MPF) would not contribute to XDRP1 phosphorylation, because cyclin B does not bind to XDRP1 ( Figure 4E ) and no phosphorylated form of GST-XDRP1 was observed when cyclin B was expressed in the extracts (unpublished data).
The binding of XDRP1 with cyclin A does not require a state of XDRP1 phosphorylation, because cyclin A1 can bind to both phosphorylated and dephosphorylated forms of XDRP1 (data not shown). But, vice versa, phosphorylation of XDRP1 depends upon its binding to cyclin A, because the N-terminal deletion of cyclin A (161-418) failed to phosphorylate XDRP1 completely (data not shown). Taken together, XDRP1 would be associated with the cyclin A-CDK complex first ( Figure 5B ), and then phosphorylated by cyclin A-dependent kinase at M phase.
The dominant fraction of XDRP1 is located at the nucleus as the phosphorylated form ( Figure 3A and B) . Cyclin A is known to be located predominantly at the nucleus throughout the cell cycle , and its sequence does not contain a distinct nuclear localization signal. The phosphorylation of XDRP1 may be involved in localization of cyclin A at the nucleus. XDRP1 contains six putative SP sites in the middle stretch of its sequence. We are currently working on the mutation analysis of XDRP1 phosphorylation.
Possible role of XDRP1 in the regulation of cyclin A degradation in mitosis XDRP1 binds to a conserved motif in the N-terminus of cyclin A in vitro and selectively inhibits cyclin A degradation in egg extracts (Figures 6 and 7A) . Because the N-terminus of mitotic cyclin including the destruction box is required for ubiquitin-dependent proteolysis, the binding of XDRP1 to the N-terminus of cyclin A may interfere with the interaction and/or the access of some protein(s) to cyclin A, which is required for proteolytic machinery. This would be the reason why XDRP1 selectively inhibits cyclin A degradation in Xenopus egg extracts and embryos.
The state of XDRP1 phosphorylation is not directly related to the binding ability with cyclin A or cyclin A-CDK (data not shown). Rather, the conformational change of cyclin A-CDK complex through XDRP1 binding to cyclin A would be an important step for cyclin A degradation, probably by protecting the cyclin substrate from the attack of the ubiquitin-dependent proteasome pathway. So far, we cannot detect a strong interaction between XDRP1 and cyclin A in vivo. However, we suspect that XDRP1 might function through interaction with cyclin A in cells, because XDRP1 is specific for cyclin A as characterized by their interaction in cells and by a block of its degradation. A simple idea to explain our results is therefore that the selective binding of XDRP1 with cyclin A may be involved in the negative regulation of cyclin A degradation. The N-terminal ubiquitin-like domain is also shown to be essential for XDRP1 interaction with cyclin A. For example, Rad23, a protein containing the N-terminal ubiquitin-like domain, appears to interact with a subunit of XP-C to stabilize the repair complex XP-C (Reardon et al., 1996; Schauber et al., 1998) . So, as shown previously for XP-C, XDRP1 containing a ubiquitin-like sequence in its N-terminus might function as a molecular chaperone of the cyclin-CDK complex to protect the cyclin A substrate.
Several reports imply that mitotic cyclins must be protected from its degradation machinery under physiological conditions, even in a state of active proteasome in mitosis Kobayashi et al., 1994; Chen et al., 1997) . However, it is not yet clear whether the protection of cyclin A from degradation is of any biological significance. We are currently investigating this point, including other potential binding partners of XDRP1 in two-hybrid screens.
Materials and methods
Cloning of XDRP1
The N-terminal fragment of cyclin A1 (1-160) was obtained by PCR method using pGEM1-cyclin A1 (Minshull et al., 1990) as a template and two oligonucleotides (5Ј-GATACATATGCGGCGCAGTATGGCTT-CCA-3Ј and 5Ј-TATGGATCCTTAAGCTACAGCATCAGGGTCT-3Ј) as primers. The DNA fragment was digested with NdeI and BamHI and subcloned into the multi-cloning site of PAS404 (a gift from E.Noguchi) 5016 to obtain PAS404-A1 (1-160). Saccharomyces cerevisiae strain Y190 (a gift from N.Hayashi) was transformed with PAS404-A1 (1-160) linearized with XbaI. The expression of N-terminal cyclin A1 in the transformant was checked by immunoblotting. The transformant was then retransformed with Xenopus oocyte Matchmaker cDNA library (unfertilized oocytes from Xenopus laevis, ages 1-3 years; injected with a gonadotropin library, cloned into pGAD10 vector, Clontech). Fifty-three colonies that could grow on synthetic medium minus histidine plus 25 mM 3-aminotriazole were obtained from 1.8 ϫ 10 8 transformants. Of those, 41 expressed β-galactosidase by filter assay as described in Clontech Matchmaker user manual. The partial sequence analysis of these candidates using a GAL4ADSP primer (5Ј-AATACCACTACA-ATGGATG-3Ј) revealed 20 to be identical, and termed this clone XDRP1. A 2.3 kb stretch of full-length XDRP1 cDNA covers a 5Ј UTR, an ATG initiation codon, a complete single ORF (1755 nucleotides) encoding 585 amino acids, two stop codons, a 3Ј UTR and a polyadenylation signal at the 3Ј end. We used this clone for further analysis (DDBJ/ EMBL/GenBank accession No. AB030502). An alternative spliced form of XDRP1 consisting of 600 amino acid residues was obtained by the screening of Xenopus cDNA library (5Ј-Stretch, oocyte from X.laevis, λgt10; Clontech).
Purification of bacterially expressed GST-XDRP1 protein
A PCR fragment of XDRP1 was obtained using two oligonucleotides (5Ј-AAGAATTCTCATGGCGGAGAGCGGCGCTGAT-3Ј and 5Ј-TGA-GATGGTGCACGATGCAC-3Ј) as primers and XDRP1 cDNA as a template. The DNA fragment was digested with EcoRI and subcloned into the multi-cloning site of pGEX-KG vector. The construct was used to transform the Escherichia coli strain BL21(DE3). The mid-log phase culture was induced with 0.5 mM IPTG and was grown at 26°C for 6 h. The cells were pelleted by centrifugation and frozen at -20°C. The pellet was thawed and suspended in lysis buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol, 0.25% Tween 20, 1 mM DTT, 1 mM APMSF). The cells were broken by sonication at a medium intensity for 10 min. The lysate was centrifuged in a Beckman TLA-100 rotor at 45 000 r.p.m. for 45 min. The supernatant was incubated with glutathioneSepharose 4B (Pharmacia Biotech) for 2 h at 4°C with rotating. The Sepharose beads were washed three times with lysis buffer and then resuspended and washed with ATP buffer [50 mM Tris-HCl pH 7.5, 10 mM Mg(OAc) 2 , 100 mM KOAc, 10 mM ATP] and incubated at 30°C for 20 min. Then the beads were washed with beads-wash buffer (50 mM Tris pH 7.5, 150 mM NaCl, 50 mM DTT, 1 mM APMSF, 0.25% Tween 20) before eluting with the elute buffer (50 mM Tris pH 7.5, 150 mM NaCl, 50 mM DTT, 1 mM APMSF, 0.25% Tween 20, 50 mM reduced glutathione). The eluate containing GST-XDRP1 protein was concentrated and the buffer was replaced into XB (10 mM K-HEPES pH 7.7, 50 mM KCl, 2 mM MgCl 2 ) using an Ultrafree-4 centrifugal filter Biomax NMWL membrane (Millipore) before freezing in liquid nitrogen and storing at -80°C. For microinjection, GST-XDRP1 and GST were dissolved in 10 mM HEPES pH 7.7 and 88 mM NaCl. The GST-XDRP1 protein prepared by this method demonstrated a purity of~90% or more.
Xenopus extracts
Xenopus oocytes and embryos, and the CSF-arrested extracts and interphase extracts were prepared by the standard methods of Murray's protocol . For activation of Xenopus eggs, squeezed eggs were treated by 2 μg/ml of ionophore A23187 and the activated eggs were incubated at 20°C in 0.1ϫ MMR. At 10 min intervals, eggs were sampled (equivalent to one-tenth egg) and subjected to SDS-PAGE and immunoblotting with anti-XDRP1 antibody.
Antibodies, immunoblotting and immunoprecipitation
Bacterially expressed GST-XDRP1 was cleaved by thrombin and XDRP1 protein was recovered through elution from GST-Sepharose beads. This protein was used as an antigen for raising anti-XDRP1 antiserum in rabbits. To apply an affinity purification of anti-XDRP1 antibody, XDRP1 protein was absorbed to a HiTrap affinity column (1 ml, Amersham Pharmacia Biotech). Anti-XDRP1 antibody bound to XDRP1 protein in this affinity column was eluted by 100 mM glycine, pH 2.8. The eluate was neutralized by 1 M Tris-HCl, pH 8.0. Anti-XDRP1 antiserum, diluted at 1:3000, was used for imunoblotting. Xenopus egg extracts labelled with [ 35 S]methionine (1 μCi/μl) were immuniprecipitated by affinity purified anti-XDRP1 antibody and the precipitates were analysed by SDS-PAGE, followed by autoradiography. The monoclonal Xenopus anti-cyclin B2 antibody and Xenopus anti-cyclin A1 were a gift from J.Gannon, and rabbit polyclonal Xenopus anti-cyclin A1 antibody was obtained from M.Carrington, University of Cambridge, Cambridge, UK. Xenopus anti-cyclin A2 was the gift of M.Howell, ICRF, London, UK.
XDRP1 binding in vitro
mCAP RNA capping kit (Stratagene) was used for in vitro transcription. pGEM1-cyclin A1, pGEM1-cyclin B1, pGEM1-cyclin B2, myc-tagged cyclin A1 (ESP11), ESP11-cyclin A2 and human cyclin A were used as templates. mRNAs were added at 0.1 μg/μl and 0.5 μCi of [ 35 S]methionine in 20 μl of the reaction mixed extracts [80% of reticulocyte lysate (Amersham) and 20% of Xenopus CSF-arrested extracts]. After incubation at 23°C for 40 min, the GST or GST-XDRP1 protein was added to the extracts and incubated at 23°C for 80 min. The reaction was diluted with 400 μl of RIPA buffer (50 mM Tris-HCl pH 7.5, 0.5% sodium deoxycholate, 0.1% SDS, 1% NP-40, 150 mM NaCl, 25 mM APMSF, 1 mM DTT) and 10 μl of glutathione-Sepharose beads was added and incubated for 1 h at 4°C with rotation. The beads were washed with RIPA buffer three times. Proteins bound to GSH beads were detected by SDS-PAGE and autoradiography. and Xenopus cyclin A2 were subcloned into the multi-cloning site of vector pCDNA with N-terminal T7-His 6 tags and with N-terminal HA tag, respectively. To obtain pCDNA T7-His-XDRP1, the PCR product of pGAD10-XDRP1 as a template using oligonucleotides ATGGATCCATGGCGGAGAGCGGCGCTGAT and TGAGATGGTGCACGATGCAC was digested by BamHI. The digested PCR fragment was subcloned into the BamHI site of the plasmid pCDNA with T7-His tags. Similarly, to obtain pCDNA HA-cyclin A2, the PCR product of Xenopus pGEM1-cyclin A2 as a template using oligonucleotides GGTCGGTAGCGGCCGCATGTCTGACCATCTGCT-GCGG and TAAGATATCTTATAAAAATGTAGACATCGA was digested with NotI and EcoRV. The PCR fragment was subcloned into NotI and EcoRV sites of HA-tagged pCDNA (both HA-tagged pCDNA and T7-His 6 tagged pCDNA, were given by T.Sekiguchi).
Transfection and binding assay
Xenopus fibroblast WAK cells were cultured in a medium for Xenopus cell line (65% modified Eagle's medium, 10% fetal calf serum, 20 mM HEPES pH 7.2, 100 μg/ml penicillin and 100 μg/ml streptomycin) at 26°C (Kobayashi et al., 1992) . WAK cells were transfected with HAtagged cyclin A2 and T7-His-tagged XDRP1 in pCDNA at~80% confluence on a 10 cm dish using 60 μl of Superfect Transfection Reagent (Qiagen). These cells were incubated for 24 h at 26°C. The transfected cells (1 ϫ 10 7 cells) were lysed on ice in 1 ml of modified lysis buffer A (10 mM HEPES pH 7.5, 150 mM NaCl, 1 mM EGTA, 0.5% Triton X-100, 1 mM APMSF, 1 mg/ml leupeptin and 1 mg/ml aprotinin; Qian et al., 1998) for 50 min on ice with occasional rocking. The lysates were clarified by centrifugation at 10 000 g for 15 min. The 900 μl of supernatants were incubated with 10 μl of TALON metal affinity resin (Clontech) for 2 h at 4°C and washed with modified lysis buffer A three times. 3ϫ SDS-sample buffer was added to the beads and boiled for 3 min.
Immunofluorescence
Xenopus WAK cells were cultured asynchronously in the medium, as described, on coverslips overnight. The coverslips were rinsed in CMFM (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 7.5 mM Tris-HCl, pH 7.6) three times at room temperature and fixed for 10 min in CMFM containing 4% paraformaldehyde for 10 min. Coverslips were washed with CMFM, then incubated with CMFM containing 1% Triton X-100 for 10 min. The coverslips were incubated with blocking solution [CMFM containing 5% gelatin (from cold water fish skin, Sigma), 1% Tween 20, 3% ovalbumin, 10% normal goat serum] for 1 h and incubated with affinity purified anti-XDRP1 antibody (1:100) for 1 h. After washing three times with CMFM containing 1% Tween 20, coverslips were incubated with secondary antibody (fluorescein conjugated-goat antirabbit antibody, Biosource International, 1:500). The secondary antibody was incubated on the fixed WAK cells to remove any background before use. After 45 min of incubation, the coverslips were washed with CMFM containing 1% Tween 20. Vectashield with DAPI (Vector Laboratories) was used for mounting on glass slides. Photographs were taken using a Neofluar 40ϫ lens (Zeiss) on Kodak Ektachrome DNYA 400.
Subcellular fractionation
Xenopus WAK cells were removed by scraping and washing three times with CMFM buffer. Cell pellets were suspended in pre-chilled hypotonic buffer (10 mM Tris-HCl pH 7.4, 10 mM NaCl, 1.5 mM MgCl 2 , 1 mM APMSF) and incubated on ice for 15 min. The cell suspension was homogenized with 10-20 strokes in a Dounce homogenizer and centri-5017 fuged at 1000 g for 5 min. The supernatant contained cytoplasm was centrifuged at 1000 g for 5 min to remove cell debris. The pellet contained nuclei was then washed with hypotonic buffer. Three micrograms of the fractionated proteins were analyzed by SDS-PAGE and immunoblotting. The proteins of nuclear fraction were prepared from 4-fold equivalent cells, compared with cytoplasmic ones.
Treatment by phosphatase and CDK inhibitor
The CSF-arrested extracts (3 μl) were added to 17 μl of the reaction mixture of λ-phosphatase (10 U/μl of λ-phosphatase, 50 mM Tris-HCl pH 7.5, 0.1 mM EDTA, 5 mM DTT, 0.01% Brij 35, 2 mM MnCl 2 ) and incubated at 30°C for 1 h in the presence or absence of phosphatase inhibitor cocktail (5 mM sodium fluoride, 5 mM sodium phosphate pH 8.0, 10 mM sodium pyrophosphate, 5 mM EGTA, 5 mM EDTA, 0.1 mM sodium orthovanadate; Randez-Gil et al., 1998) . To analyse the phosphorylation of purified GST-XDRP1 protein, cyclin A1 mRNA was translated in CSF/Retic-mixed extracts (1:1) at 23°C for 40 min, and then 1 μg of GST-XDRP1 protein was added. After incubation for 80 min, GST-XDRP1 protein was retained with glutathione-Sepharose beads, and treated in 20 μl of the reaction containing 10 U/μl of λ-phosphatase as described above. The bead-bound GST-XDRP1 was detected by immunoblotting with anti-XDRP1 antibody. For CDK inhibitory assay, cyclin A1 mRNA was translated in CSF/Retic-mixed extracts (1:1) at 23°C for 40 min, and then 1 μg of GST-XDRP1 protein and the increasing amounts of butyrolactone I (provided by M.Kitagawa) were added to the extracts. After incubation for 60 min, GST-XDRP1 was detected by immunoblotting with anti-XDRP1 antibody.
Histone H1 kinase assay
Xenopus cyclin A1 mRNA was translated in CSF/Retic-mixed extracts (1:1) with [ 35 S]methionine at 23°C for 40 min, and GST-XDRP1 was added to the extracts and incubated for 80 min. GST-XDRP1 was recovered by the GSH beads as described above. The beads were washed with the washing buffer (20 mM Tris-HCl, 7.5 mM MgCl 2 ) and then incubated with reaction mixture (20 mM Tris-HCl pH 7.5, 7.5 mM MgCl 2 , 0.2 mM ATP, 10 μCi [γ-32 P]ATP, 100 μg/ml histone H1) for 30 min at 23°C. The samples were analyzed by SDS-PAGE and autoradiography (overnight exposure). 35 S-labelled cyclin A1 and cyclin B2 as the substrate were prepared by in vitro translation in the mixed extracts (50% reticulocyte lysate and 50% CSF-arrested extracts) and added to the pure CSF-arrested extracts. Normally, 1-2 μl of the extracts containing labelled cyclin A1 and cyclin B2 was added to 15 μl of pure CSF-arrested extracts. GST or GST-XDRP1 protein was added. CaCl 2 was then added to 0.4 mM final concentration and the samples was taken at the indicated times and were analysed by SDS-PAGE and autoradiography. The addition of at least 50 ng/μl of GST-XDRP1 to the extracts exhibited an inhibitory effect on the degradation of cyclin A.
Degradation assay and immunodepletion
For immunodepletion, protein A beads (Affiprep, Bio-Rad) were precoated with affinity purified anti-XDRP1 antibody (2 mg/ml) and washed in XB buffer. The beads were added to CSF-arrested extracts (20% v/v) containing 250 μg/ml cycloheximide, and incubated for 1 h at 4°C with rotation. The beads were removed by centrifugation and the supernatants were used as depleted extracts.
Microinjection of Xenopus embryo
Unfertilized eggs were inseminated with sperm, and then dejellied in 0.3ϫ MBS (Gurdon, 1991) containing 2% cysteine for 5 min. Dejellied embryos were transferred to 0.3ϫ MBS containing 3% Ficoll (Type 400-DL) for microinjection. GST or GST-XDRP1 protein (60 ng each) was injected into embryos at one-cell stage (50-60 min after fertilization). The injected embryos were allowed to develop in 0.3ϫ MBS medium. These embryos were fixed with 5% trichloroacetic acid for 30 min and photographed at 3 h after injection.
